Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.990
-0.160 (-3.11%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 533 employees as of December 31, 2025. The number of employees increased by 165 or 44.84% compared to the previous year.
Employees
533
Change (1Y)
165
Growth (1Y)
44.84%
Revenue / Employee
$404,730
Profits / Employee
-$515,672
Market Cap
301.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 533 | 165 | 44.84% |
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| EyePoint | 214 |
| Zentalis Pharmaceuticals | 106 |
| SAB Biotherapeutics | 86 |
| Upstream Bio | 75 |
| InflaRx | 65 |
| Sionna Therapeutics | 59 |
| Immuneering | 57 |
VNDA News
- 19 hours ago - Vanda Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 days ago - Vanda Pharmaceuticals Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 13 days ago - Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences - PRNewsWire
- 22 days ago - Vanda awarded Orphan Designation in Europe for treatment of GPP - TheFly
- 22 days ago - Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission - PRNewsWire
- 24 days ago - NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. - PRNewsWire
- 5 weeks ago - Vanda Pharmaceuticals price target lowered to $12 from $17 at B. Riley - TheFly
- 5 weeks ago - Vanda Pharmaceuticals price target lowered to $20 from $21 at H.C. Wainwright - TheFly